Haeger, Knut
September 1964
Angiology;Sep1964, Vol. 15 Issue 9, p417
Academic Journal
Chlorthalidone, polythiazide and hydrofluomethazine were compared for their effect on venous stasis edema in 728 patients. Investigation of body weight, ankle and calf circumference demonstrated that all three drugs had a remarkable effect on reduction of the size of the edematous leg, and caused a decrease of body weight. Chlorthalidone and polythiazide were similarly effective in the doses given, whereas hydrofluomethazine exerted a less pronounced effect. On the contrary hydrofluomethazine had practically no side effects, whereas the other two drugs caused undesirable side reactions in 8 per cent (chlorthalidone) and 6.2 per cent (polythiazide) of the cases. In two series of patients an earlier empiric impression of the beneficial effect of diuretics in leg ulcer treatment was confirmed. The healing quotients of one series of patients on the standard ulcer therapy of the clinic, including diuretics, and of another series on the same therapy with diuretics excluded were statistically different favouring the ‘diuretics series.’ It is concluded that diuretics are beneficial in states of venous stasis edema, with or without leg ulcers.


Related Articles

  • First report of palpebral oedema: case report.  // Reactions Weekly;2/26/2005, Issue 1040, p17 

    Summarizes a case report on the development of palpebral oedema in a man after taking tadalafil for erectile dysfunction. Medical history of the patient; Situation when the recurrence of oedema appear.

  • Pharmacokinetics of mono-3′- and mono-4′-0-(β-hydroxyethyl)-rutoside derivatives, after single doses of Venoruton powder in healthy volunteers. Kienzler, J.-l.; Sallin, D.; Schifflers, M.-H.; Ghika, A. // European Journal of Clinical Pharmacology;Sep2002, Vol. 58 Issue 6, p395 

    Background. Venoruton is a standardised mixture of O-(β-hydroxyethyl) rutosides (HR) used for the relief of oedema and related symptoms in patients with chronic venous insufficiency. Objectives. The primary objective was to evaluate the pharmacokinetic parameters, in particular the rate and...

  • Advantage of a Micronized Flavonoidic Fraction (Daflon 500 mg) in Comparison with a Nonmicronized Diosmin. Amato, C. // Angiology;Jun1994 Supplement, Vol. 45, p531 

    A randomized, double-blind, multicenter trial was performed to study the pharmacodynamics and clinical activities of Daflon 500 mg, in comparison with a nonmicronized diosmin. Daflon 500 mg is a micronized purified flavonoidic fraction consisting of 450 mg of diosmin and 50 mg of hesperidin per...

  • Review: Horse chestnut seed extract is effective for symptoms of chronic venous insufficiency: COMMENTARY. Kahn, Susan R. // ACP Journal Club;Jul/Aug2006, Vol. 145 Issue 1, p20 

    The article presents the author's views on a study that reports on the efficacy of horse chestnut seed extract (HCSE) for treatment of chronic venous insufficiency. The author reveals that HCSE is herbal remedy and a potential alternative to reduce swelling caused by venous hypertension. It is...

  • RELIEF Study: First Consolidated European Data. Jantet, Georges // Angiology;Jan2000, Vol. 51 Issue 1, p31 

    The RELIEF study (Reflux assessment and quaLity of life improvement with micronized Flavonoids in chronic venous insufficiency [CVI]) is a prospective, controlled, multicenter, international study performed in patients with or without venous reflux. This study was conducted between March 1997...

  • Chronic Venous Insufficiency. Buczkowski, Glenn; Munschauer, Cary; Vasquez, Michael A. // Clinician Reviews;Mar2009, Vol. 19 Issue 3, p18 

    The article focuses on the public's increasing awareness of chronic venous insufficiency (CVI) and the emergence of options to relieve patients' symptoms and improve cosmetic appearance. It discusses the mechanisms of the disease as well as the risk factors including prolonged standing and...

  • Paroven.  // Royal Society of Medicine: Medicines;2002, p428 

    This article provides information on paroven, a proprietary, non-prescription preparation of oxerutins. It can be used to treat cramp and other manifestations of poor circulation in the veins (venous insufficiency), such as oedema, and is available as capsules.

  • Chronic Venous Disease, Inflammation, and Daflon 500 mg. Nicolaides, A. N. // Angiology;Sep/Oct2005 Supplement 1, Vol. 56, p1 

    Reports on the clinical efficacy of Daflon 500 mg in relieving early symptoms, improving quality of life and relieving edema in patients with chronic venous disease. Superiority of the drug over conventional methods in the healing of venous ulcers; Investigation on inflammatory products as...

  • Arterial Embolization as a Treatment of Chronic Edema Following Free Cutaneous Flap Transfer to the Lower Limbs. Charlemagne Noukoua Tchuisse; Ali Barah; Alain Nchimi; Robert F. Dondelinger // CardioVascular & Interventional Radiology;Jun2003, Vol. 26 Issue 3, p316 

    Persisting chronic edema following postoperative free flap transfer is a common complication. We report 3 cases of successful treatment by selective arterial embolization of the feeding arterial branches without side effect. One session embolization is advocated as a first line treatment of this...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics